
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>pmid: 6110574
ABSTRACTThe author proposes that current regulations governing the licensing of drugs, particularly in the United States, need to be changed and replaced by a system of provisional or conditional licensing and increased postmarketing surveillance of drug use.
Adult, Male, Risk, Clinical Trials as Topic, United States Food and Drug Administration, Drug Evaluation, Preclinical, Contraceptives, Oral, Synthetic, United States, Animals, Drug Evaluation, Drug and Narcotic Control, Humans
Adult, Male, Risk, Clinical Trials as Topic, United States Food and Drug Administration, Drug Evaluation, Preclinical, Contraceptives, Oral, Synthetic, United States, Animals, Drug Evaluation, Drug and Narcotic Control, Humans
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
